R21TW012728
Project Grant
Overview
Grant Description
Development of Implementation Toolkits to Promote HPV Self-Sampling Behavior Among Women Living with HIV in Ghana - Abstract
Women living with HIV, (WLWH), in low- and middle-income countries (LMICs) have a six-fold increased risk of developing cervical cancer (CC) compared to their uninfected counterparts. Our studies in Ghana show that self-sampling is acceptable, easy to use, and efficacious in detecting precancer lesions among WLWH. However, this screening mechanism has not been translated to healthcare practice in Ghana.
Systematic adaptation and implementation toolkits are needed to translate self-sampling into healthcare practices. We develop a home-based self-collected sampling for the cervical cancer prevention education (HOPE) toolkits to promote cervical cancer screening in Ghana. HOPE toolkit core components such as (a) self-sample HPV testing kits and (b) the 3R (Reframe, Reprioritize, and Reform) communication model will not change as they are evidence-based.
The content and the intervention delivery modalities of HOPE will go through the cultural adaptation iterative processes. This R21 resubmission seeks to develop contextually appropriate adaptation and implementation toolkits in Ghana. A three-step approach will be used for the adaption process and evaluation of the toolkit.
First, we will organize focus group discussions to identify contextual factors affecting the toolkit adaptation and nominal group techniques to determine the different compositions of the toolkits and select the final toolkit. A sample of 35 stakeholder advisory board members representing three organizational levels: potential intervention participants (i.e., WLWH), community leaders, and healthcare workers (e.g., doctors, nurses, administrators) will participate in the FGDS and NGTS.
Second, we will recruit 45 participants including WLWH and healthcare workers to evaluate the feasibility, acceptability, appropriateness, and adoptability of the selected toolkit. Third, we will test the preliminary efficacy of HOPE on cervical cancer screening defined as cervical cancer screening uptake among WLWH in the intervention arm (N=54) and control arm (N = 54). Participants will be recruited from the Cape Coast Teaching Hospital (CCTH).
Specific aims of HOPE are: Aim I: Develop and adapt the HOPE toolkit: Hypothesis: Stakeholders will identify and prioritize community needs and translate findings into a culturally adapted toolkit. Aim II: Evaluate the characteristics of the HOPE toolkit: Hypothesis: We hypothesize that 80% of participants will find HOPE toolkits feasible, acceptable, appropriate, and adoptable. Aim III: Assess the efficacy of HOPE on CCS. Hypothesis: We hypothesize that CCS behavior will increase significantly among women in the intervention group compared to those in the control group. Aim IV: Identify actionable factors and implementation costs that influence the adoption of the toolkit. Hypothesis: The actionable factors and implementation costs will significantly influence the toolkit adoption.
Women living with HIV, (WLWH), in low- and middle-income countries (LMICs) have a six-fold increased risk of developing cervical cancer (CC) compared to their uninfected counterparts. Our studies in Ghana show that self-sampling is acceptable, easy to use, and efficacious in detecting precancer lesions among WLWH. However, this screening mechanism has not been translated to healthcare practice in Ghana.
Systematic adaptation and implementation toolkits are needed to translate self-sampling into healthcare practices. We develop a home-based self-collected sampling for the cervical cancer prevention education (HOPE) toolkits to promote cervical cancer screening in Ghana. HOPE toolkit core components such as (a) self-sample HPV testing kits and (b) the 3R (Reframe, Reprioritize, and Reform) communication model will not change as they are evidence-based.
The content and the intervention delivery modalities of HOPE will go through the cultural adaptation iterative processes. This R21 resubmission seeks to develop contextually appropriate adaptation and implementation toolkits in Ghana. A three-step approach will be used for the adaption process and evaluation of the toolkit.
First, we will organize focus group discussions to identify contextual factors affecting the toolkit adaptation and nominal group techniques to determine the different compositions of the toolkits and select the final toolkit. A sample of 35 stakeholder advisory board members representing three organizational levels: potential intervention participants (i.e., WLWH), community leaders, and healthcare workers (e.g., doctors, nurses, administrators) will participate in the FGDS and NGTS.
Second, we will recruit 45 participants including WLWH and healthcare workers to evaluate the feasibility, acceptability, appropriateness, and adoptability of the selected toolkit. Third, we will test the preliminary efficacy of HOPE on cervical cancer screening defined as cervical cancer screening uptake among WLWH in the intervention arm (N=54) and control arm (N = 54). Participants will be recruited from the Cape Coast Teaching Hospital (CCTH).
Specific aims of HOPE are: Aim I: Develop and adapt the HOPE toolkit: Hypothesis: Stakeholders will identify and prioritize community needs and translate findings into a culturally adapted toolkit. Aim II: Evaluate the characteristics of the HOPE toolkit: Hypothesis: We hypothesize that 80% of participants will find HOPE toolkits feasible, acceptable, appropriate, and adoptable. Aim III: Assess the efficacy of HOPE on CCS. Hypothesis: We hypothesize that CCS behavior will increase significantly among women in the intervention group compared to those in the control group. Aim IV: Identify actionable factors and implementation costs that influence the adoption of the toolkit. Hypothesis: The actionable factors and implementation costs will significantly influence the toolkit adoption.
Awardee
Funding Goals
THE JOHN E. FOGARTY INTERNATIONAL CENTER (FIC) SUPPORTS RESEARCH AND RESEARCH TRAINING TO REDUCE DISPARITIES IN GLOBAL HEALTH AND TO FOSTER PARTNERSHIPS BETWEEN U.S. SCIENTISTS AND THEIR COUNTERPARTS ABROAD. FIC SUPPORTS BASIC BIOLOGICAL, BEHAVIORAL, AND SOCIAL SCIENCE RESEARCH, AS WELL AS RELATED RESEARCH TRAINING AND CAREER DEVELOPMENT. THE RESEARCH PORTFOLIO IS DIVIDED INTO SEVERAL PROGRAMS THAT SUPPORT A WIDE VARIETY OF FUNDING MECHANISMS TO MEET PROGRAMMATIC OBJECTIVES.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Texas
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 77% from $201,823 to $357,127.
Baylor University was awarded
HPV Self-Sampling Toolkit for Women Living with HIV in Ghana
Project Grant R21TW012728
worth $357,127
from Fogarty International Center in April 2024 with work to be completed primarily in Texas United States.
The grant
has a duration of 1 year 9 months and
was awarded through assistance program 93.989 International Research and Research Training.
The Project Grant was awarded through grant opportunity Dissemination and Implementation Research in Health (R21 Clinical Trial Optional).
Status
(Ongoing)
Last Modified 1/21/25
Period of Performance
4/1/24
Start Date
1/31/26
End Date
Funding Split
$357.1K
Federal Obligation
$0.0
Non-Federal Obligation
$357.1K
Total Obligated
Activity Timeline
Transaction History
Modifications to R21TW012728
Additional Detail
Award ID FAIN
R21TW012728
SAI Number
R21TW012728-1097922329
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NF00 NIH FOGARTY INTERNATIONAL CENTER
Funding Office
75NF00 NIH FOGARTY INTERNATIONAL CENTER
Awardee UEI
C6T9BYG5EYX5
Awardee CAGE
4F219
Performance District
TX-90
Senators
John Cornyn
Ted Cruz
Ted Cruz
Modified: 1/21/25